BETNOVATE ong tb 30 g
7680309700202
Pharmacode 139784
CH-30970
D07AC01
10.05.1.
Active substances:
Reimbursement limitations:
ICLUSIG
ICLUSIG est remboursé chez les patients adultes atteints de - Leucémie myéloïde chronique à chromosome …
1 / 2
Fiches Amavita / Sun Store / Coop Vitality
Details
- GTIN
- 7680309700202
- Pharmacode
- 139784
- Product number
- 3097001
- CPT
- -
- Packaging group
- 30
- Unit
- g
- Composition
- betamethasonum 1 mg ut betamethasoni valeras, paraffinum liquidum, vaselinum album, ad unguentum pro 1 g.
Articles (1)
Betnovate, Salbe
Salbe
30
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
betamethasonum
|
1.0 MG | Substance | Wirkstoff (Principe actif) |
|
betamethasoni valeras
|
- | Substance | WIZUS |
|
paraffinum liquidum
|
- | Substance | HNIDK |
|
vaselinum album
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 12.75
Specialties list
Yes
Generic
No
SL addition date:
15/03/1965
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 30970
- Drug name
- Betnovate, Salbe
- Galenic form
- SALB
- ATC Code
- D07AC01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 16/10/1964
- Authorization expiration date
- 31/12/9999
- IT number
- 10.05.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BETNOVATE ong tb 30 g
- Description (DE)
- BETNOVATE Salbe Tb 30 g
- Market launch
- 16/10/1964
- Narcotic (BTM)
- No